Oncotarget is a medical journal, which is peer-reviewed on a weekly basis, covering research papers on all dimensions of oncology. The medical journal was instituted in 2010, and Impact Journals did the publishing. The journal has two chief editors, Mikhail Blagosklonny and Andrei v. Gudkov from the Roswell Park Cancer Institute.
Mikhail Blagosklonny is an Associate Editor of Therapy and Cancer Biology, a member of Cell Death and Differentiation, Editorial Board and an Editor In Chief of Oncotarget, Ageing of Cells and Cell Cycle Journals. He is a professor of Oncology at the esteemed Roswell Park Cancer Center in Buffalo, New York. Roswell Park is one the institutions that offer comprehensive cancer treatment.
Visit ResearchGate to keep up to date with Mikhail’s latest work.
Oncotarget is a multidisciplinary journal featuring free access. The Journal posts the peer-reviewed papers every week. Additionally, each issue of the journal may be printed on special demand. The mission of the Oncotarget is to make scientific research results and papers rapidly and widely available. This is with the aim of maximizing the impact of research, as well as allowing discoveries to be shared instantly. By eliminating the border between the specialties, Oncotarget strived to link up the different fields in the biomedical sciences.
Under the leadership tenure of elite scientists, Oncotarget assists researcher add to the progress and growth of science. The journal’s primary goal is for people to live healthy, free from any diseases. Currently, Oncotarget offers free alt-metric reports for articles to provide real-time tracking of medical articles in both traditional and digital media platforms on Facebook. Furthermore, to the benefit of researchers and other scientists, Oncotarget is soon launching sections, in addition to oncology. Such additional categories include cardiology, endocrinology, immunology, pharmacology, MoI Biology and neuropathology cell among others.
The editors at Oncotarget are tasked with the responsibility of evaluating manuscripts on merit, quality of data, scientific novelty, and presentation regardless of the author’s citizenship, race, religious affiliations, and sexual orientation. The decision to publish a medical article is not founded on political policies and other agencies, rather the journal itself. The chief editors have the authority over all the editorial content of the journal even during the time of publishing.
The editorial staff is required not to disclose any information regarding the manuscripts to anyone other than the authors, reviewers, members of the editorial board and potential reviewers. Editors are additionally not allowed to utilize an unpublished material for other purposes but are required to keep the information confidential. The editorial team assesses the manuscripts without significant conflicts of interests stemming from collaborative, competitive, as well as other connections with the respective authors.
View Mikhail’s profile on Loop.